A Study Investigating the Efficacy and Safety of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Conditions
Interventions
- DRUG: Lampalizumab
- OTHER: Sham
Sponsor
Hoffmann-La Roche